Publication: In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac
The JRC published a study on a new type of targeted cancer treatment that uses radioactive antibodies to attack tumors with a HER2 marker. The treatment showed strong stability and effectiveness...